Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2158575 | Radiotherapy and Oncology | 2011 | 4 Pages |
Abstract
Survival and prognostic factors were similar to those found in the literature. Boost delivered after WBRT by a conventional particle accelerator could provide a benefit in selected patients, especially for centers that do not have radiotherapy techniques in stereotactic conditions. This warrants further prospective assessment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Avi Assouline, Antonin Levy, Cyrus Chargari, Ioannis Lamproglou, Jean-Jacques Mazeron, Claude Krzisch,